Eli Lilly & Co. just announced that they are going to buy Sigilon Therapeutics for $14.92 per share. Why are they buying it for a much higher share price than through the stock exchange where the closed quote was $3.93 per share?
In: 53
They buy at a premium to incentivize enough people to sell their shares that they end up with control of the company.
Latest Answers